Historical record - last NADAC effective date: 7/17/2024
Product Information
IBANDRONATE SODIUM 150 MG TAB is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $3.2323 per EA under NDC 55111057503. Its NADAC has been published 558 times since Nov 28, 2013.
FDA first approved this application on Apr 30, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
55111057503
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
7/17/2024
Active Ingredients
IBANDRONATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA078997FDA Approved
4/30/2012
TE Code
AB
On Market Since
6/21/2012
Pharmacological Classes
Price Statistics
The NADAC for IBANDRONATE SODIUM 150 MG TAB has been published 558 times since Nov 28, 2013, and over the history we have for it it has declined 92.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2323 per EA |
|---|---|
| All-time high | $44.9978 (Dec 11, 2013) |
| All-time low | $3.2323 (Jul 17, 2024) |
| Median price | $6.7212 |
| Average price | $12.9399 |
| Largest weekly change | -23.4% (Jan 18, 2017) |
| Weeks tracked | 558 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-14.5%
5Y
-50.8%
All
-92.8%
Last surveyed Jul 31, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ibandronate sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bisphosphonate class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IBANDRONATE SODIUM 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IBANDRONATE SODIUM 150 MG TAB, manufactured by Dr. Reddy's Laboratories Inc., is $3.2323 per EA (NDC 55111057503), effective Jul 31, 2024.
How has the price of IBANDRONATE SODIUM 150 MG TAB changed over time?
Over the history we have for it, the NADAC for IBANDRONATE SODIUM 150 MG TAB has declined 92.8%. It has been tracked across 558 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IBANDRONATE SODIUM 150 MG TAB?
Since Nov 28, 2013, the NADAC for IBANDRONATE SODIUM 150 MG TAB has ranged from a low of $3.2323 (Jul 17, 2024) to a high of $44.9978 (Dec 11, 2013), with a median of $6.7212 per EA.
Are there cheaper alternatives to IBANDRONATE SODIUM 150 MG TAB?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBANDRONATE SODIUM 150 MG TAB, is $2.6751 per EA — about 17% below IBANDRONATE SODIUM 150 MG TAB.
Who manufactures IBANDRONATE SODIUM 150 MG TAB?
IBANDRONATE SODIUM 150 MG TAB (NDC 55111057503) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.